Enveric Biosciences Statistics
Total Valuation
ENVB has a market cap or net worth of $6.63 million. The enterprise value is $1.72 million.
Important Dates
The last earnings date was Friday, May 15, 2026, before market open.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ENVB has 3.68 million shares outstanding. The number of shares has increased by 814.40% in one year.
| Current Share Class | 3.68M |
| Shares Outstanding | 3.68M |
| Shares Change (YoY) | +814.40% |
| Shares Change (QoQ) | +128.96% |
| Owned by Insiders (%) | 3.65% |
| Owned by Institutions (%) | 3.48% |
| Float | 3.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.67 |
| P/TBV Ratio | 1.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.67
| Current Ratio | 11.67 |
| Quick Ratio | 10.66 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20,000.21 |
Financial Efficiency
Return on equity (ROE) is -183.12% and return on invested capital (ROIC) is -114.44%.
| Return on Equity (ROE) | -183.12% |
| Return on Assets (ROA) | -96.72% |
| Return on Invested Capital (ROIC) | -114.44% |
| Return on Capital Employed (ROCE) | -162.43% |
| Weighted Average Cost of Capital (WACC) | 10.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.93M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.37% in the last 52 weeks. The beta is 1.10, so ENVB's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | -88.37% |
| 50-Day Moving Average | 2.67 |
| 200-Day Moving Average | 5.15 |
| Relative Strength Index (RSI) | 32.53 |
| Average Volume (20 Days) | 182,190 |
Short Selling Information
The latest short interest is 115,974, so 3.15% of the outstanding shares have been sold short.
| Short Interest | 115,974 |
| Short Previous Month | 886,509 |
| Short % of Shares Out | 3.15% |
| Short % of Float | 3.27% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.22M |
| Pretax Income | -8.22M |
| Net Income | -11.58M |
| EBITDA | -8.06M |
| EBIT | -8.22M |
| Earnings Per Share (EPS) | -$17.16 |
Full Income StatementBalance Sheet
The company has $4.91 million in cash and n/a in debt, with a net cash position of $4.91 million or $1.33 per share.
| Cash & Cash Equivalents | 4.91M |
| Total Debt | n/a |
| Net Cash | 4.91M |
| Net Cash Per Share | $1.33 |
| Equity (Book Value) | 5.06M |
| Book Value Per Share | 2.68 |
| Working Capital | 4.91M |
Full Balance SheetCash Flow
| Operating Cash Flow | -8.01M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 157,074 |
| Net Borrowing | n/a |
| Free Cash Flow | -8.01M |
| FCF Per Share | -$2.17 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
